FDA Orders Vision Alert

The FDA has instructed makers of a dozen GLP-1 drugs, including Ozempic and Wegovy, to add warnings about a rare eye condition that can cause permanent vision loss. Its review found about six cases per 100,000 patients taking the drugs over a year, compared with fewer than four among patients receiving placebo or other glucose-lowering medications, but said the findings do not establish that the drugs cause the condition.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article